BTBA-Boston Taiwanese Biotechnology Association

06/03/2026

新型藥物模式：RNA 干擾、蛋白質降解與基因編輯的交會

下一代療法正如何在 DNA、RNA 與蛋白質層面交會，並重新定義疾病治療的可能性？本場 Panel 將邀集基因編輯、RNA 干擾與靶向蛋白質降解領域的專家，深入比較不同藥物模式的作用機制、適用情境與技術取捨，並探討從遞送方式、口服可行性、臨床轉譯到組合策略等挑戰，以及未來三年最值得關注的產業趨勢。

講者陣容：
📍 David Bryson - 透過 base editing 與 prime editing 技術，推動精準基因編輯在治療應用上的發展。
📍 Ho-Chou Tu - 專注 RNAi 新標靶探索與驗證，推進從早期研究到臨床開發的治療管線。
📍 Mikolaj Slabicki - 透過靶向蛋白質降解、molecular glues 與 PROTACs，拓展可成藥蛋白質標靶的可能性。

📅 活動日期： 2026 年 7 月 11–12 日
📍
活動地點： 哈佛大學 Northwest Building
歡迎轉發給親友、同事與所有熱愛生技領域的人士。 期待與您在 BTBA 2026年會相見！

🎟️立即報名，一同參與北美最大台灣人生技盛會之一！
👉 購票連結：https://buytickets.at/btba/2137594

———————

Novel Drug Modalities: The Convergence of Genome Editing, RNA Interference, and Protein Degradation

Explore how next-generation therapeutics are reshaping medicine by converging across DNA, RNA, and protein. Brings together leaders in genome editing, RNA interference, and targeted protein degradation to compare how each modality works, where each performs best, and what challenges remain. From delivery and oral formulation to clinical translation, combination strategies, and the key industry trends expected to define the next three years for patients, clinicians, and developers alike.

Speakers:
📍 David Bryson - Advancing precision genome editing through base and prime editing technologies for therapeutic applications.
📍 Ho-Chou Tu - Driving RNAi target discovery and validation from early-stage biology to clinical development.
📍 Mikolaj Slabicki - Expanding the druggable proteome through targeted protein degradation, molecular glues, and PROTACs.

📅
Date: July 11–12, 2026
📍
Location: Northwest Building, Harvard University

🎟️Registration is Now Open!
👉https://buytickets.at/btba/2137594

🔍 For the full agenda and speaker details, visit

Feel free to share with anyone passionate about biotech. We can’t wait to see you at the BTBA Symposium 2026!

05/31/2026

Decoding Gene Delivery: Comparative Strategies in AAV, LNP, and VLP Technologies

The success of next-generation gene therapies doesn’t rely on a single delivery method, but on choosing the right tool for the right therapeutic goal. As the landscape of genetic medicine expands, understanding the distinct applications, advantages, and trade-offs of different delivery platforms is critical.

Join us for an expert panel discussion with industry and academic leaders. We’ll explore the strategies and challenges of each different delivery platform throughout drug discovery and pipeline development.

🗓️ Date: July 11, 2026
🕑 Time: 2:00 PM - 3:00 PM EDT
📍 Location: Northwest Building, Harvard University

Our panelists:
Mattijs Bulcaen – Postdoctoral Affiliate, Broad Institute
Jin Qiu – Director, PackGene Biotech
Jilong Li – Principal Scientist, CRISPR Therapeutics

Bring your questions to our live Q&A as we map the future of gene delivery! From early discovery to complex manufacturing, this is one critical conversation you don't want to miss.

⭐️Early bird ticket sales are ending soon! Secure your ticket before June 7 and join one of the largest Taiwanese biotech gatherings in North America.
👉 https://lnkd.in/d-4YiBjS

🔍 View the full agenda and speaker lineup here:
👉 https://lnkd.in/exdVp83R

📢 Poster Submission Now Open!
Share your research, connect with the biotech community, and compete for a $30 USD gift card plus free symposium admission!
This is a great chance to share your work and connect with the biotech community!

👉 Submit your poster here: https://lnkd.in/ezw395fQ (Submission deadline: May 31)
Feel free to share with friends, colleagues, and anyone passionate about biotech. We look forward to seeing you at BTBA 2026!

解密基因遞送：AAV、LNP 與 VLP 技術比較

新一代基因療法的成功，靠的不再是單一的遞送方法，而是為特定的治療目標挑選出最合適的工具。我們很開心邀請了業界與學界的專家們來聊聊，帶大家一起探討在藥物開發的各個階段中，這些遞送方法的策略運用與面臨的挑戰。

🗓️日期：2026 年 7 月 11 日
🕑時間：下午 2:00 – 3:00 (美東時間 EDT)
📍地點：哈佛大學 Northwest Building

歡迎來和我們一起探討基因遞送的未來趨勢，期待與您在BTBA 2026相見！

⭐️早鳥票優惠即將結束！6/7前敬請把握機會，一同參與北美最大台灣人生技盛會之一！
👉 https://lnkd.in/d-4YiBjS

🔍 查看完整議程與講者資訊：
👉 https://lnkd.in/exdVp83R

📢 海報投稿現正開放中！
歡迎分享您的研究，免費參加年會並有機會獲得 30 美元禮品卡！別錯過與生技社群交流與曝光的絕佳平台！

👉 海報投稿連結：https://lnkd.in/ezw395fQ (投稿截止日: 5/31)
💬 歡迎轉發給親友、同事與所有熱愛生技領域的人士，期待與您在 BTBA 2026年會相見！

05/31/2026

Navigating Leadership: Real-World Scenarios & Open Discussion

📅 Saturday, June 13, 2026 | 12:30-3:00 PM
📍 Room B10, Science Center, Harvard University (1 Oxford St, Cambridge, MA 02138)
Registration link: https://forms.gle/3VQAVAZ9sa7P6PDJ9

⏰ Event starts at 1:00 PM

About the Event
This interactive workshop uses real-world workplace scenarios to explore leadership, communication, conflict management, visibility, and career development in bio/pharma. Scenarios will be acted in English, while discussions remain open in both English and Mandarin.
Through immersive case studies and open discussion, participants will gain practical insights beyond technical skills and connect with peers navigating similar career challenges.

Featured Leadership Scenarios:
🔹 Influence Without Authority
Managing peers and direct reports while communicating across different leadership levels.
🔹 The Misaligned Lab
When expectations around independence, communication, and project ownership are unclear.
🔹 The Quiet Contributor
Why strong performance sometimes goes unseen—and strategies to increase visibility and career growth.

Meet mentees from this year's mentorship program and hear firsthand experiences on leadership growth and career navigation.

Agenda
12:30–1:00 | Networking
1:00–1:30 | Introduction + Scenario Demonstrations
1:30–2:30 | Interactive Group Discussions
2:30–2:45 | Wrap-up
3:00–3:45 | BTBA Monthly Meeting: Annual Meeting Discussion
🎭 Scenarios performed in English
🌎 Open bilingual discussion (English + Mandarin)

你是否曾遇過以下情境？
▪️ 沒有正式主管職稱，卻需要推動跨部門合作？
▪️ 團隊對工作分工與責任認知不同，導致溝通困難？
▪️ 明明表現優秀，卻總是缺乏能見度與發展機會？

BTBA 誠摯邀請您參加本次 Leadership Workshop。我們將透過真實職場案例演繹與互動討論，深入探討生技與製藥產業中常見的領導力挑戰，包括溝通協調、衝突管理、團隊合作、個人能見度與職涯發展等重要議題。

本次活動將以沉浸式情境案例（Scenario-Based Learning）帶領大家思考，並透過小組交流分享不同觀點與實務經驗，幫助參與者培養技術能力之外的重要職場軟實力。

✨ 精選案例主題
🔹 Influence Without Authority｜沒有職權，如何發揮影響力？
在跨部門合作中，如何有效與同儕、主管及不同層級的利害關係人溝通協調。
🔹 The Misaligned Lab｜團隊期待不一致怎麼辦？
當獨立性、溝通方式與專案責任分工不明確時，如何建立共識與信任。
🔹 The Quiet Contributor｜優秀表現為何沒被看見？
探討提升個人能見度、建立影響力與職涯成長的實用策略。
此外，我們也將邀請本年度 Mentorship Program 的 mentees 分享參與心得，交流在領導力發展與職涯探索中的實際收穫與挑戰。

📋 活動流程
12:30 – 1:00 PM｜Networking
1:00 – 1:30 PM｜活動介紹與情境演示
1:30 – 2:30 PM｜互動式小組討論
2:30 – 2:45 PM｜總結與分享
3:00 – 3:45 PM｜BTBA 月會（Annual Symposium Discussion）

🎭 情境演示以英文進行
🌎 討論採中英雙語開放交流

歡迎學生、博士後研究員、產業從業人員，以及對領導力與職涯發展有興趣的朋友一同參與。期待與大家交流學習！

05/29/2026

Happy to assist with this webinar with wonderful people and wonderful topics. Looking forward to seeing you there.
BATBA與BTBA一起合作舉辦的East Meets West in Biopharm 報名中！
2026 年 6 月 6 日 5:00 PM PDT/8:00 PM EDT
Online Webinar:https://www.zeffy.com/.../east-meets-west-in-biopharma

BATBA 座談介紹系列3
BATBA與BTBA一起合作舉辦的East Meets West in Biopharm 報名中！
本次邀請了來自曾在美東及美西都工作過的講者，一起來跟我們來聊聊他們橫跨美國的寶貴經驗，講座以中文進行。
✨主持人 / 講者：Brian Wei（韋佩勛）博士
Brian 是生物製藥分析領域的資深專家，在分離科學（Separation Science）與生物製程分析（BioProcess Analytics）方面具備深厚底蘊。他擁有逾 20 年的化學專業經驗，研究範疇廣泛涵蓋有機合成、化學生物學與分析化學。
現任職務與核心貢獻 目前，Brian 擔任賽諾菲（Sanofi）首席科學家暨分離科學團隊經理。自 2021 年加入全球化學製造與管制（CMC）開發部門以來，他致力於為複雜生物製劑與新興治療模式推動前瞻性的分析策略。他的核心工作聚焦於分離科學的創新，並積極開發結合人工智慧（AI）與自動化技術的生物製程分析解決方案。
豐富的業界經歷 在加入賽諾菲前，Brian 長期深耕於美國西岸的頂尖生技與科學儀器產業：
🧬SCIEX（Danaher 集團）｜洛杉磯都會區 (2019–2021)： 領導跨部門研發團隊，成功推動創新蛋白質分離技術的開發與商業化。期間推出了 BioPhase 8800 系統，以及應用於 PA800 Plus 的多款分析試劑與平台（涵蓋 Glycan、RNA、CE-SDS 及 cIEF 等）。
🧬ProteinSimple（Bio-Techne 集團）｜舊金山灣區： 帶領跨部門團隊投入蛋白質分析儀器與方法的研發，包括分析軟體演算法的開發與優化，重要專案包含 iCE/Maurice、Simple Western 系統及單細胞 Western（Single-Cell Western）技術。
🧬BioVidria（新創公司）： 負責層析技術、親和材料與分析方法的開發。他運用普渡大學的授權技術，投入 UHPLC（超高壓液相層析）管柱與免疫奈米微珠的研發，以提升藥物開發與疾病檢測的效能。
學歷與學術背景 Brian 先於奧克蘭大學（Oakland University）取得有機合成化學碩士學位，隨後在普渡大學（Purdue University）獲得化學博士學位（專攻分析化學、有機合成及化學生物學）。在普渡大學期間，他為合成化學、藥物傳遞及生物分離分析儀器開發奠定了扎實的基礎，並於畢業後成功將這些學術量能轉化為工業界的實際應用。
⏰2026 年 6 月 6 日 5:00 PM PDT/8:00 PM EDT
📍Online Webinar:https://www.zeffy.com/en-US/ticketing/east-meets-west-in-biopharma

05/28/2026

📣📣📣 Dear BTBA friends, we warmly invite you to be part of something exciting! Submit your poster abstract for the 2026 BTBA Annual Symposium for a chance to win a $30 gift card and have your registration fee waived. The submission deadline is now extended to 5/31. Don’t miss this excellent opportunity to share your amazing work—we can’t wait to meet you! 🙌

📩 Poster Submission Link: https://tinyurl.com/92p84vde
📁 Poster Abstract Template: https://tinyurl.com/2k2zmnh6
📅 Abstract Submission Deadline: May 31, 2026 (11:59 PM EDT)
📢 Oral Presentation Winners Notifications: June 7, 2026

📣📣📣 不知不覺來到了五月底，距離2026 年 BTBA 年會只剩不到兩個月了！除了參加年會的演講活動以外，你想要跟大家一起分享在實驗室花費無數心血的成果嗎？只要提交海報摘要，就免除年會報名費，另外還有機會贏得 $30 禮品卡！這麼好康的機會，還不快動動手指報名～如今海報投稿的截止日延長至5/31，歡迎大家踴躍報名！ 🙌

📩 海報投稿連結： https://tinyurl.com/92p84vde
📁 海報摘要模板： https://tinyurl.com/2k2zmnh6
📅 海報投稿截止：2026 年 5 月31 日 晚間11:59（美東時間）
📢 公告演講錄取名單： 2026 年 6 月 7 日

海報設計/Poster Design： Hao Chung

05/25/2026

⚜️ BTBA 第14屆年會早鳥購票及海報投稿即將結束！ ⚜️

🎟️ Early bird pricing ends 5/31 — don’t miss out!
Ticket Registration: https://www.tickettailor.com/events/btba/2137594

📝 Poster submission 現正開放！延長至 5/31 截止！
投稿者可享免費入場，並有機會獲選進行 oral presentation！
Poster Submission: https://tinyurl.com/92p84vde

今年 BTBA 將於 Harvard 舉辦兩天年度生技論壇，聚焦 AI、精準醫療、基因治療、RNA 技術、合成生物學與新型藥物開發，邀請來自學界與產業領袖，共同探討生技醫藥的未來。

今年 keynote speakers 包括：
🧬 Stephen Cho, PhD — SVP, Global Portfolio & Program Management, BeOne Medicines
🩺 Arlene Sharpe, MD, PhD — Chair of Immunology, Harvard Medical School

論壇也將涵蓋：
✨ Spatial Omics & AI in Translational Medicine
✨ AI in Healthcare
✨ Rare Disease & Precision Therapies
✨ AAV / LNP / VLP Delivery Technologies
✨ RNAi / PROTAC / Genome Editing
✨ Synthetic Biology Beyond Medicine

除了精彩演講，今年也安排：
🤝 Breakfast & Meet
🤝 Lunch Roundtables
🤝 Poster Session
🤝 Dinner Reception

⚜️ Early Bird Registration & Poster Submission ends soon for the 14th Annual BTBA Symposium! ⚜️

🎟️ Early bird pricing ends May 31 — don’t miss out!
Ticket Registration: https://www.tickettailor.com/events/btba/2137594

📝 Poster submission deadline: May 31!
Accepted poster presenters receive FREE admission and may be selected for an oral presentation opportunity.
Poster Submission: https://tinyurl.com/92p84vde

Join us at Harvard University for a two-day symposium exploring the future of biotech and medicine — from AI-powered healthcare and spatial omics to gene delivery, RNA therapeutics, and synthetic biology.

We are honored to welcome our keynote speakers:
🧬 Stephen Cho, PhD — SVP of Global Portfolio & Program Management, BeOne Medicines
🩺 Arlene Sharpe, MD, PhD — Chair of Immunology, Harvard Medical School

Featured topics include:
✨ Spatial Omics & AI in Translational Medicine
✨ AI in Healthcare
✨ Rare Disease Genomics & Precision Therapies
✨ AAV / LNP / VLP Delivery Technologies
✨ RNAi, Protein Degradation & Genome Editing
✨ Synthetic Biology Beyond Medicine

In addition to scientific sessions, the symposium will feature:
🤝 Breakfast & Meet
🤝 Lunch Roundtables
🤝 Poster Session
🤝 Dinner Reception

05/24/2026

🚀 Leadership isn't learned from slides. It's built through real situations.

Join Navigating Leadership: Real-World Scenarios & Open Discussion

📅 Sat, June 13, 2026 | 12:30–3:00 PM
📍 Room B10, Science Center, Harvard University (1 Oxford St, Cambridge, MA 02138)

Explore immersive case scenarios on:
🔹 Managing without authority
🔹 Misaligned expectations in research teams
🔹 Why great work can still go unnoticed

Meet people from this year's mentorship program, hear real career stories, and join interactive discussions with peers in bio/pharma.

🎭 Scenarios performed in English
🌎 Discussion open & bilingual

Grow your leadership toolkit beyond the lab.

05/24/2026

Spatial Omics and AI in Translational Medicine

Discover how next-generation spatial biology and AI are transforming the future of disease research and precision medicine. Advances in spatial genomics, digital pathology, and computational imaging are enabling unprecedented insights into tissues, tumors, and cellular ecosystems at single-cell resolution. Join leaders from academia and industry to explore the next frontier of translational medicine.

Speakers:
📍Jiang He – Pioneering single-cell spatial genomics technologies to advance next-generation biomedical research and precision medicine.
📍Ben Glass – Leading the development of AI-powered digital pathology and translational research platforms for precision healthcare.
📍Jia-Ren Lin – Advancing spatial imaging and computational pathology to decode tumor ecosystems and tissue biology at single-cell resolution.

⭐️Early bird ticket sales are ending soon! Secure your ticket before May 30 and join one of the largest Taiwanese biotech gatherings in North America.
👉 https://www.tickettailor.com/events/btba/2137594

🔍 View the full agenda and speaker lineup here:
👉 https://www.btbatw.org/2026/

📢 Poster Submission Now Open!
Share your research, connect with the biotech community, and compete for a $30 USD gift card plus free symposium admission
This is a great chance to share your work and connect with the biotech community!
👉 Submit your poster here: https://tinyurl.com/92p84vde (Submission deadline: May 24)

📅 Date: July 11–12, 2026
📍 Location: Northwest Building, Harvard University

Feel free to share with friends, colleagues, and anyone passionate about biotech. We look forward to seeing you at BTBA 2026!

空間體學與人工智慧於轉譯醫學中的應用

新世代空間體學與人工智慧如何改變疾病研究與精準醫療的未來？
空間基因體學、數位病理與計算影像等技術的進步，使我們能以前所未有方式以單細胞與組織層級解析度，深入揭示腫瘤、組織與細胞微環境的奧秘。誠摯邀請學界與產業界的大家，共同探索轉譯醫學的下一個新篇章！

講者陣容:
📍Jiang He – 致力於開發單細胞空間基因體技術，推動新世代生醫研究與精準醫療發展。
📍Ben Glass – 專注於 AI 數位病理與轉譯研究平台開發，推動人工智慧於精準醫療中的臨床應用。
📍Jia-Ren Lin – 運用空間影像與計算病理技術，以單細胞分辨率探索腫瘤微環境與組織生物學。

⭐️早鳥票優惠即將結束！5/30前敬請把握機會，一同參與北美最大台灣人生技盛會之一！
👉 https://www.tickettailor.com/events/btba/2137594

🔍 查看完整議程與講者資訊：
👉 https://www.btbatw.org/2026/

📢 海報投稿現正開放中！
歡迎分享您的研究，免費參加年會並有機會獲得 30 美元禮品卡！別錯過與生技社群交流與曝光的絕佳平台！
👉 海報投稿連結： https://tinyurl.com/92p84vde (投稿截止日: 5/24)

📅 活動日期：2026 年 7 月 11–12 日
📍 地點：哈佛大學 Northwest Building

💬 歡迎轉發給親友、同事與所有熱愛生技領域的人士，期待與您在 BTBA 2026年會相見！

05/21/2026

BTBA 2026 年會 Keynote Speaker 盛大公開！ 📣

相信大家期待已久了！我們非常榮幸邀請到免疫學與癌症治療領域的頂尖權威，哈佛大學 University Professor Arlene Sharpe, MD, PhD，擔任 BTBA 2026 Annual Symposium 的 Keynote Speaker。

Dr. Sharpe 現任哈佛大學 Kolokotrones 大學教授暨哈佛醫學院免疫學系主任。她同時也是 Brigham and Women’s Hospital、Broad Institute 及 Dana-Farber/Harvard Cancer Center 的研究員。

作為 T 細胞共刺激（T cell costimulation）領域的先驅，Dr. Sharpe 的實驗室首先闡明 CTLA-4 與 PD-1 路徑的免疫抑制功能，為現今癌症的「免疫檢查點阻斷療法」（immune checkpoint blockade therapy）奠定了深厚的基礎。迄今她已發表過超過 400 篇學術論文，為美國國家科學院、國家醫學院及美國文理科學院院士，並榮獲 Warren Alpert Foundation Prize、Harrington Prize 等無數醫學界頂級殊榮。

今年年會中，Arlene 將分享她的實驗室如何從基礎研究出發，探討 T 細胞共刺激路徑在調節免疫耐受性、抗腫瘤免疫中的關鍵角色。她將帶領聽眾了解如何將這些突破性的科學理解，成功轉化為對抗自體免疫疾病與癌症的創新療法，以及作為頂尖科學家的養成、投入、進而無私的奉獻。

對於對 immunology、cancer biology、immunotherapy、translational medicine 或學術研究與臨床轉化有興趣的朋友，這將是一場不容錯過的 keynote！敬請期待！

📢早鳥票販售即將截止！請於5/30前購票！

Announcing the Keynote Speaker for the BTBA 2026 Annual Symposium! 📣

The wait is finally over! We are thrilled to announce that Arlene Sharpe, MD, PhD, Harvard University Professor and a leading authority in immunology and cancer treatment, will join us as the Keynote Speaker for the BTBA 2026 Annual Symposium. Dr. Sharpe currently serves as the Kolokotrones University Professor at Harvard University and Chair of the Department of Immunology at Harvard Medical School. She is also a researcher at Brigham and Women’s Hospital, the Broad Institute, and the Dana-Farber/Harvard Cancer Center.

As a pioneer in the field of T cell costimulation, Dr. Sharpe's laboratory was the first to elucidate the immunoinhibitory functions of the CTLA-4 and PD-1 pathways, laying a profound foundation for today's immune checkpoint blockade therapy in cancer. To date, she has published over 400 academic papers , is an elected member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences , and has been recognized with numerous top-tier medical honors, including the Warren Alpert Foundation Prize and the Harrington Prize.

In this year's symposium, Arlene will share how her laboratory, starting from basic research, explores the critical roles of T cell costimulatory pathways in regulating immune tolerance and antitumor immunity. She will guide the audience through how these breakthrough scientific understandings are successfully translated into innovative therapies against autoimmune diseases and cancer, as well as reflect on her journey, dedication, and selfless contributions in her development as a top-tier scientist.

For those interested in immunology, cancer biology, immunotherapy, translational medicine, or the transition from academic research to clinical applications, this is a keynote you cannot afford to miss! Stay tuned!

📢Early bird ticket sales are ending soon! Please purchase your ticket before May 30!

05/18/2026

Personalized cancer immunotherapy: Multi-adjuvant neoantigen vaccines

Personalized neoantigen-targeting vaccines represent a major frontier in precision oncology. It is designed to activate the immune system of individual cancer patients to fight against their unique somatic mutations. While identifying high-quality coding mutations via whole-exome and RNA sequencing is a critical first step, the ultimate success relies heavily on vaccine formulation. That being said, antigenic precision must be matched by robust adjuvant-based activation strategies to overcome the vast clonal heterogeneity of cancer cells and suppressive microenvironments of different cancer types.

In this talk, Dr. Derin Keskin from the Dana-Farber Cancer Institute will walk us through the clinical and biological evolution of personalized synthetic long-peptide vaccines. He will explore the trajectory of this platform across high- and low-mutational-burden cancers, including melanoma and glioblastoma. We invite you to join us for a deep dive into how complementary neoantigen identification and adjuvant-based activation mechanisms are essential for the next generation of cancer vaccines.

Event detail:
Date: May 23rd, 2026 (Saturday)
Place: Lehman Hall 201, Harvard University & Online
Time:
12:30 pm - 1:00 pm (ET) Networking
1:00 pm - 1:40 pm (ET) Talk: Personalized cancer immunotherapy: Multi-adjuvant neoantigen vaccines
1:40 pm - 1:55 pm (ET) Q&A
1:55 pm - 2:15 pm (ET) Break & Networking
2:15 pm - 3:15 pm (ET) BTBA monthly meeting
👇Register here: 👇
https://forms.gle/rM92ydSjwRwHYs5b7

個人化癌症免疫治療：多重佐劑新生抗原疫苗

個人化新生抗原疫苗是當前精準腫瘤治療的新興療法，其核心在於針對每位癌症患者特有的體細胞突激發專屬的免疫攻擊。利用次世代定序（WES & RNA-seq）精準得知病人的突變是研發此類疫苗的重要步驟，但疫苗能否在臨床上取得成功，很大程度上取決於其配方設計。精準的抗原選擇必須搭配強效的免疫激活策略 - 佐劑（Adjuvant)，才能有效克服腫瘤的高度異質性以及不同癌症類型中具有免疫抑制性的腫瘤微環境。本次講座Dr. Derin Keskin將帶領我們回顧「個人化合成長胜肽」疫苗這幾年的發展，並探討此疫苗平台在高突變負荷與低突變負荷癌症（包括黑色素瘤和膠質母細胞瘤）中的應用。

📆 活動詳情：
🗓️ 日期：5月23日（星期六）
⏰ 時間：美東時間（EDT）下午 1:00
💻 形式：Lehman Hall 201, Harvard University + Zoom 線上會議（報名成功後寄送連結）
🗣️ 語言：英文進行
👇 點此報名 👇
https://forms.gle/rM92ydSjwRwHYs5b7